An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors

NCT00030043 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

FED

Sponsor class

Conditions

Neurofibromatosis 2

Interventions

DEVICE: Penetrating auditory brainstem implant

Sponsor

FDA Office of Orphan Products Development